Strata Skin Sciences, Inc.
SSKN
$1.42
-$0.05-3.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.99% | -38.10% | 19.99% | 7.41% | -29.59% |
| Total Depreciation and Amortization | -9.12% | -6.06% | -8.29% | -10.08% | -10.60% |
| Total Amortization of Deferred Charges | 14.60% | 22.83% | 20.00% | 5.71% | -10.46% |
| Total Other Non-Cash Items | 22.30% | 24.65% | -9.06% | -4.77% | 43.99% |
| Change in Net Operating Assets | -84.66% | 89.92% | -89.33% | 1,013.04% | 160.80% |
| Cash from Operations | -316.36% | -142.46% | 187.35% | 136.22% | 150.03% |
| Capital Expenditure | 41.75% | 72.86% | 71.91% | 67.40% | 43.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 41.75% | 72.86% | 71.91% | 67.40% | 43.00% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.82% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 100.00% | 87.05% | 97.18% |
| Cash from Financing | 13.87% | 1,692.62% | -71.61% | -71.94% | -69.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,813.04% | 76.22% | -46.54% | -63.95% | 80.29% |